202 related articles for article (PubMed ID: 35632550)
41. Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis.
Cheng H; Peng Z; Si S; Alifu X; Zhou H; Chi P; Zhuang Y; Mo M; Yu Y
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891263
[TBL] [Abstract][Full Text] [Related]
42. Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals.
Lapa D; Grousova DM; Matusali G; Meschi S; Colavita F; Bettini A; Gramigna G; Francalancia M; Garbuglia AR; Girardi E; Puro V; Antinori A; Kovyrshina AV; Dolzhikova IV; Shcheblyakov DV; Tukhvatulin AI; Zubkova OV; Gushchin VA; Logunov DY; Naroditsky BS; Vaia F; Gintsburg AL
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632574
[TBL] [Abstract][Full Text] [Related]
43. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
Front Immunol; 2021; 12():747830. PubMed ID: 34858404
[TBL] [Abstract][Full Text] [Related]
44. Omicron Booster in Ancestral Strain Vaccinated Mice Augments Protective Immunities Against Both Delta and Omicron Variants.
Jia L; Zhou Y; Li S; Zhang Y; Yan D; Wang W; Zhang W; Wan Y; Qiu C
Front Immunol; 2022; 13():897879. PubMed ID: 35874751
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
46. Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination.
Hernández-Luis P; Aguilar R; Pelegrin-Pérez J; Ruiz-Olalla G; García-Basteiro AL; Tortajada M; Moncunill G; Dobaño C; Angulo A; Engel P
Front Immunol; 2022; 13():816389. PubMed ID: 35464418
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine.
Chansaenroj J; Suntronwong N; Kanokudom S; Assawakosri S; Yorsaeng R; Vichaiwattana P; Klinfueng S; Wongsrisang L; Srimuan D; Thatsanatorn T; Thongmee T; Auphimai C; Nilyanimit P; Wanlapakorn N; Sudhinaraset N; Poovorawan Y
Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891235
[TBL] [Abstract][Full Text] [Related]
48. Performance comparison between heterologous and homologous COVID19 vaccine schedules on Omicron variant incidence: A real-world retrospective cohort study in Southern Italy.
Baglivo F; Magrì M; De Angelis L; Aprile V; Minelli M; Stifini R; Lopalco P; Rizzo C; Fedele A
Vaccine; 2023 Sep; 41(39):5687-5695. PubMed ID: 37567798
[TBL] [Abstract][Full Text] [Related]
49. Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.
Chen Q; Du P; Han Y; Ma X; Zhang R; Rong X; Zhao X; Ma R; Yang H; Zheng A; Huang Q; Yan J; Wang H; Zhao X; Dai L; Gao GF; Wang Q
Biosaf Health; 2023 Apr; 5(2):89-100. PubMed ID: 37123450
[TBL] [Abstract][Full Text] [Related]
50. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.
Edara VV; Manning KE; Ellis M; Lai L; Moore KM; Foster SL; Floyd K; Davis-Gardner ME; Mantus G; Nyhoff LE; Bechnak S; Alaaeddine G; Naji A; Samaha H; Lee M; Bristow L; Hussaini L; Ciric CR; Nguyen PV; Gagne M; Roberts-Torres J; Henry AR; Godbole S; Grakoui A; Sexton M; Piantadosi A; Waggoner JJ; Douek DC; Anderson EJ; Rouphael N; Wrammert J; Suthar MS
bioRxiv; 2021 Dec; ():. PubMed ID: 34981056
[TBL] [Abstract][Full Text] [Related]
51. Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees.
Anichini G; Terrosi C; Gandolfo C; Gori Savellini G; Fabrizi S; Miceli GB; Franchi F; Cusi MG
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632563
[TBL] [Abstract][Full Text] [Related]
52. Humoral Responses in the Omicron Era Following 3-Dose SARS-CoV-2 Vaccine Series in Kidney Transplant Recipients.
McEvoy CM; Hu Q; Abe KT; Yau K; Oliver MJ; Levin A; Gingras AC; Hladunewich MA; Yuen DA
Transplant Direct; 2023 Jan; 9(1):e1401. PubMed ID: 36518793
[TBL] [Abstract][Full Text] [Related]
53. Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.
Vogt AS; Augusto G; Martina B; Chang X; Nasrallah G; Speiser DE; Vogel M; Bachmann MF; Mohsen MO
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632499
[TBL] [Abstract][Full Text] [Related]
54. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
[TBL] [Abstract][Full Text] [Related]
55. Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2.
Ghosh AK; Landt O; Yeasmin M; Sharif M; Ratul RH; Molla MA; Nafisa T; Mosaddeque MB; Hosen N; Bulbul MRH; Mamunur R; Islam A; Shakil SS; Kaiser M; Amin MR; Lytton SD
Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36423054
[TBL] [Abstract][Full Text] [Related]
56. Post-Vaccination Neutralization Responses to Omicron Sub-Variants.
Jacobsen H; Katzmarzyk M; Higdon MM; Jiménez VC; Sitaras I; Bar-Zeev N; Knoll MD
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298622
[TBL] [Abstract][Full Text] [Related]
57. Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
Chandrashekar A; Yu J; McMahan K; Jacob-Dolan C; Liu J; He X; Hope D; Anioke T; Barrett J; Chung B; Hachmann NP; Lifton M; Miller J; Powers O; Sciacca M; Sellers D; Siamatu M; Surve N; VanWyk H; Wan H; Wu C; Pessaint L; Valentin D; Van Ry A; Muench J; Boursiquot M; Cook A; Velasco J; Teow E; Boon ACM; Suthar MS; Jain N; Martinot AJ; Lewis MG; Andersen H; Barouch DH
bioRxiv; 2022 Feb; ():. PubMed ID: 35169798
[TBL] [Abstract][Full Text] [Related]
58. Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake.
Mallory M; Munt JE; Narowski TM; Castillo I; Cuadra E; Pisanic N; Fields P; Powers JM; Dickson A; Harris R; Wargowsky R; Moran S; Allabban A; Raphel K; McCaffrey TA; Brien JD; Heaney CD; Lafleur JE; Baric RS; Premkumar L
medRxiv; 2023 Apr; ():. PubMed ID: 37066219
[TBL] [Abstract][Full Text] [Related]
59. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
[TBL] [Abstract][Full Text] [Related]
60. Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections.
Möhlendick B; Čiučiulkaitė I; Elsner C; Anastasiou OE; Trilling M; Wagner B; Zwanziger D; Jöckel KH; Dittmer U; Siffert W
Front Immunol; 2022; 13():907343. PubMed ID: 35812411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
